03:45 , Apr 13, 2018 |  BC Innovations  |  Targets & Mechanisms

Meeting the burden

A major theme at this year’s AACR is the abundance of preclinical discovery driven by molecular signatures in patient samples, suggesting the research community is heeding the call for studies better grounded in human data,...
07:00 , Mar 25, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Polymerase (DNA directed)-g (POLG); POLB In vitro studies suggest that inhibiting DNA polymerases POLG and POLB could help treat cancers deficient in either of...
08:00 , Jan 7, 2002 |  BC Week In Review  |  Company News

Genzyme General, Genzyme Molecular deal

GZMO transferred its cancer diagnostics IP to GENZ's Genzyme Genetics business unit. Genzyme Genetics will have rights to cancer markers and cancer-related genes for use in diagnostic development and assumes rights to licenses GZMO has...
08:00 , Jan 2, 2002 |  BC Extra  |  Company News

GZMO, Genzyme Genetics IP deal

Genzyme Molecular (GZMO) transferred its cancer diagnostics IP to Genzyme Genetics, a business unit of Genzyme (GENZ). Genzyme Genetics ( Cambridge , Mass.) will have rights to cancer markers and cancer-related genes for use in...
08:00 , Mar 19, 2001 |  BC Week In Review  |  Company News

Genzyme Molecular, Mayo Medical Laboratories, Quest Diagnostics, SRL Inc. deal

GZMO granted the three parties a non-exclusive license to its APC and MSH2 genes, for use in colon cancer diagnostics. GZMO, which will receive upfront payments and royalties under the three deals, said that APC...
07:00 , Oct 2, 2000 |  BC Week In Review  |  Company News

Myriad Genetics sales and marketing update

MYGN launched its Colaris test that detects mutations in MLH1 and MSH2 genes associated with hereditary colorectal and uterine cancer. Myriad Genetics Inc. (MYGN), Salt Lake City, Utah   Business: Diagnostics/Imaging  ...
08:00 , Dec 6, 1993 |  BC Week In Review  |  Company News

Johns Hopkins University other research news

Scientists have discovered a gene responsible for an inherited form of colon cancer that will lead to a diagnostic test for people at risk due to family history of the disease, hereditary non-polyposis colorectal cancer....